Last reviewed · How we verify
NCT03079180: TAGE
Tendon Adaptations to Training - Effect of Ageing
NA trial testing Strength training at 80% 1RM in Aging in 60 participants. Status unknown.
28 July 2017
Quick facts
| Lead sponsor | Université de Technologie de Compiegne |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | supportive care |
| Enrollment | 60 |
| Start date | 13 February 2017 |
| Primary completion | 28 July 2017 |
| Estimated completion | 28 July 2017 |
| Sites | 1 location across France |
Drugs / interventions tested
- Strength training at 80% 1RM
- Strength training at 55% 1RM
Conditions studied
- Aging — all drugs for Aging →
- Exercise Training — all drugs for Exercise Training →
- Connective Tissue — all drugs for Connective Tissue →
- Skeletal Muscle — all drugs for Skeletal Muscle →
Sponsor
Université de Technologie de Compiegne
Who can join
Adults 18 to 85, male only, with Aging or Exercise Training. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Tendons are essential structures for transmitting muscle forces to skeletal structures. A stiffer tendon will transmit muscle force faster, and then allow faster movement. Moreover, tendons are a living tissue and respond to mechanical forces by changing their metabolism as well as their structural and mechanical properties. The aim of the present study is to answer essential questions remaining unanswered that are necessary in order to optimize physical activity with ageing in humans, and thus improve quality of life in elderly. The main questions are: What is the minimal training intensity leading to tendon adaptations? What is the time-course of tendon adaptations? Does the same loading protocol lead to similar tendon adaptations for different tendons (Achilles vs Patellar) and does the same training program lead to identical tendon adaptations with age (25yrs vs 75yrs)? To answer these questions, tendon architecture and mechanical properties will be investigated in humans of different age and applying different training intensities. The kinematic of the tendon adaptations due to these different training characteristics will also be investigated. The training protocol will be applied on plantar flexors and knee extensors. MRI and ultrasound techniques as well as the use of ankle and knee ergometers will allow the quantification of possible modifications in tendon architecture and mechanical properties (tendon stiffness and Young's Modulus). This will be assessed in vivo, using ultrasound images to assess tendon displacement during an incremental maximal contraction.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Muscles adaptation to aging and training: architectural changes - a randomised trial.
Létocart AJ, Mabesoone F, Charleux F, Couppé C, et al · · 2021 · cited 30× · PMID 33441116 · DOI 10.1186/s12877-020-02000-0 -
Muscles adaptation to aging and training: Architectural changes - A randomised trial
LÉTOCART AJ, Mabesoone F, Charleux F, Couppé C, et al · · 2021 · DOI 10.21203/rs.3.rs-48408/v3
Verify or expand the search:
- PubMed search for NCT03079180
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Aging
Currently open trials in the same condition.
- NCT02831335 — Technical Development of Multi-Parametric Renocerebral MRI · recruiting
- NCT07099053 — Amyloid PET Imaging in the Baltimore Longitudinal Study of Aging · recruiting
- NCT07504068 — Effects of Physical Exercise and a Nutritional Supplement on Body Composition, Metabolic Function, and Overall Health in · NA · recruiting
- NCT07525453 — Effects of Three Different Exercise Programs on Dynamic Balance in Community-Dwelling Older Adults · NA · recruiting
- NCT07500727 — Skeletal Muscle Aging and Responsiveness in Aged People With MS · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03079180 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Université de Technologie de Compiegne
- Last refreshed: 14 March 2017
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03079180.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing